Zacks Research issued their FY2027 earnings estimates for shares of Charles River Laboratories International in a report ...

Charles River Laboratories International Inc. closed 39.25% below its 52-week high of $274.77, which the company reached on ...

Charles River Laboratories International Inc. closed 37.75% short of its 52-week high of $274.77, which the company reached on March 22nd.

Japanese drugmaker Seikagaku Corporation (TYO: 4548) announced that it has received a complete response letter (CRL) from the ...

Bell Asset Management, an investment management company, released its Q4 2024 “Bell Global Equities Fund” investor letter. A ...

Lab services company Charles River Laboratories (NYSE:CRL) will be reporting earnings tomorrow before the bell. Here’s what investors should know. Charles River Laboratories beat analysts’ revenue ...

Charles River Laboratories International, Inc. CRL reported fourth-quarter 2024 adjusted earnings per share (EPS) of $2.66, which rose 8.1% year over year. The figure surpassed the Zacks Consensus ...

Redburn Atlantic upgraded Charles River (CRL) to Neutral from Sell with an $188 price target The firm says demand in the company’s Discovery ...

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company’s research model & services segment is the leading provider of ...

Citi analyst Patrick Donnelly upgraded Charles River (CRL) to Neutral from Sell with a price target of $175, up from $155. The firm thinks ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...